Market Trends of GCircular Dichroism Spectrometers Industry
Pharmaceutical Industry is Expected to Witness Healthy Growth Over the Forecast Period
- The pharmaceutical industry is one of the largest end-users of various analytical instruments as they are intensively involved in the research and development activities of biologics and other drug molecules; hence, the use of circular dichroism spectrometers is expected to increase among the pharmaceutical companies, and the market is expected to grow.
- For instance, according to the November 2021 report of the Office for National Statistics (ONS) of the United Kingdom, the amount spent on research and development annually in the pharmaceutical industry in the United Kingdom has increased by 6% to an all-time high of GBP 5.02 billion (USD 5.99 billion), which is about 18.6 of the total research and development spending of the United Kingdom.
- Furthermore, the importance of circular dichroism spectrometers in the analytical development of biopharmaceuticals is expected to drive segment growth. For instance, according to the study published by JASCO Corporation, circular dichroism (CD) measurements can provide information regarding changes in protein structure in small quantities of samples. Since protein structure and activity are closely related, CD measurements are widely accepted in the quality control of protein, which includes biomedicines. Such studies propel the segment growth due to increased demand for circular dichroism spectrometers in the pharmaceutical industry.
- Moreover, the growing investment in drug research and development activities by the key market players in the area is further expected to increase the demand for circular dichroism spectrometers, which is expected to boost the segment's growth. For instance, in May 2022, Pfizer Inc. launched a global drug research and development center at the Indian Institute of Technology (IIT) Madras, India, with an investment of about USD 20.0 million. Therefore, due to the aforementioned factors, the pharmaceutical industry is expected to hold a significant share of the studied market over the forecast period.
- Therefore, owing to the above-mentioned factors, considerable segment growth is anticipated over the forecast period.
North America is Expected to Hold a Significant Share in the Circular Dichroism Spectrometers Market Over the Forecast Period
- The pharmaceutical industry is one of the largest end-users of various analytical instruments as they are intensively involved in the research and development activities of biologics and other drug molecules; hence, the use of circular dichroism spectrometers is expected to increase among the pharmaceutical companies, and the market is expected to grow.
- For instance, according to the November 2021 report of the Office for National Statistics (ONS) of the United Kingdom, the amount spent on research and development annually in the pharmaceutical industry in the United Kingdom has increased by 6% to an all-time high of GBP 5.02 billion (USD 5.99 billion), which is about 18.6 of the total research and development spending of the United Kingdom.
- Furthermore, the importance of circular dichroism spectrometers in the analytical development of biopharmaceuticals is expected to drive segment growth. For instance, according to the study published by JASCO Corporation, circular dichroism (CD) measurements can provide information regarding changes in protein structure in small quantities of samples. Since protein structure and activity are closely related, CD measurements are widely accepted in the quality control of protein, which includes biomedicines. Such studies propel the segment growth due to increased demand for circular dichroism spectrometers in the pharmaceutical industry.
- Moreover, the growing investment in drug research and development activities by the key market players in the area is further expected to increase the demand for circular dichroism spectrometers, which is expected to boost the segment's growth. For instance, in May 2022, Pfizer Inc. launched a global drug research and development center at the Indian Institute of Technology (IIT) Madras, India, with an investment of about USD 20.0 million. Therefore, due to the aforementioned factors, the pharmaceutical industry is expected to hold a significant share of the studied market over the forecast period.
- Therefore, owing to the above-mentioned factors, considerable segment growth is anticipated over the forecast period.